Get the Stockscreener App
17.40
2.79%
-0.50
After Hours:
17.40
Adma Biologics Inc Stock (ADMA) Forecast
The Adma Biologics Inc (ADMA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $5.8957, representing a -66.12% decrease from the current price of $17.40. The highest analyst price target is $6.2065, and the lowest is $5.5849.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ADMA Price Target
Average 4.8896
(-71.90% Downside)
Is Adma Biologics Inc (ADMA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.96 | Neutral |
| STOCH(9,6) | 20.64 | Neutral |
| STOCHRSI(14) | 14.44 | Buy |
| MACD(12,26) | -0.4882 | Sell |
| ADX(14) | 23.81 | Neutral |
| William %R | -89.68 | Buy |
| CCI(14) | -95.59 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
18.57
Sell
|
18.50
Sell
|
| MA20 |
19.54
Sell
|
19.03
Sell
|
| MA50 |
18.83
Sell
|
18.95
Sell
|
| MA100 |
18.17
Sell
|
17.54
Sell
|
| MA200 |
13.58
Buy
|
14.42
Buy
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, ADMA could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 9 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on ADMA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36.96 indicates that ADMA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 20.64 indicates that ADMA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 14.44 indicates that ADMA is oversold. This suggests that ADMA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.81 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -95.59 indicates that ADMA is still oversold but not to an extreme extent.
Long-term ADMA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Adma Biologics Inc financial reports and earnings history, Adma Biologics Inc (ADMA) stock could reach $8.4442 by 2030, $10.29 by 2040 and $12.28 by 2050. See the projected annual prices until 2050 of the Adma Biologics Inc stock below:
- Adma Biologics Inc (ADMA) is expected to reach an average price of $8.5688 in 2035, with a high prediction of $8.6788 and a low estimate of $7.822. This indicates an $-50.75% rise from the last recorded price of $17.40.
- Adma Biologics Inc (ADMA) stock is projected to chart a bullish course in 2040, with an average price target of $10.05, representing an $-42.25% surge from its current level. The forecast ranges from a conservative $9.7561 to a sky-high $10.29.
- Our analysts predict Adma Biologics Inc (ADMA) to jump -35.26% by 2045, soaring from $10.89 to an average price of $11.26, potentially reaching $11.51. While $10.89 is the low estimate, the potential upside is significant.
- Adma Biologics Inc (ADMA) stock is expected to climb by 2050, reaching an average of $12.18, a $-30.00% jump from its current level. However, a wide range of estimates exists, with high and low targets of $12.28 and $11.99, respectively, highlighting the market's uncertainty.
Adma Biologics Inc Stock (ADMA) Year by Year Forecast
Adma Biologics Inc Stock (ADMA) Price Forecast for 2025
Adma Biologics Inc Stock (ADMA) is expected to reach an average price of $4.8896 in 2025, with a high prediction of $6.4812 and a low estimate of $3.298. This indicates an -71.90% fall from the last recorded price of $17.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.5949 | $5.5849 | $6.2065 | -67.85% |
| February, 2025 | $5.7933 | $5.387 | $6.4812 | -66.71% |
| March, 2025 | $4.6817 | $4.6617 | $6.024 | -73.09% |
| April, 2025 | $4.7273 | $3.298 | $5.5438 | -72.83% |
| May, 2025 | $4.678 | $4.2744 | $5.2065 | -73.12% |
| June, 2025 | $4.4891 | $4.2291 | $5.2126 | -74.20% |
| July, 2025 | $4.7596 | $4.4312 | $5.2733 | -72.65% |
| August, 2025 | $4.718 | $4.6417 | $4.9317 | -72.89% |
| September, 2025 | $4.7964 | $4.602 | $6.0943 | -72.43% |
| October, 2025 | $4.1269 | $3.949 | $5.6127 | -76.28% |
| November, 2025 | $4.3053 | $3.8932 | $4.5453 | -75.26% |
| December, 2025 | $3.9159 | $3.8459 | $4.6195 | -77.50% |
Adma Biologics Inc Stock (ADMA) Price Forecast for 2026
The predicted value for Adma Biologics Inc (ADMA) in 2026 is set at an average of $4.1076. Estimates vary from a peak of $5.07 to a trough of $3.1452, indicating an -76.39% surge from the present price of $17.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.8343 | $3.6601 | $4.148 | -77.96% |
| February, 2026 | $4.0227 | $3.8364 | $4.3106 | -76.88% |
| March, 2026 | $4.0111 | $3.8669 | $4.2248 | -76.95% |
| April, 2026 | $4.5616 | $4.0532 | $5.07 | -73.78% |
| May, 2026 | $4.09 | $3.9258 | $4.5787 | -76.49% |
| June, 2026 | $3.7384 | $3.5442 | $4.1221 | -78.51% |
| July, 2026 | $3.7089 | $3.4326 | $4.6147 | -78.68% |
| August, 2026 | $3.8174 | $3.6032 | $3.8774 | -78.06% |
| September, 2026 | $3.5079 | $3.3879 | $3.8995 | -79.84% |
| October, 2026 | $3.5913 | $3.41 | $3.6742 | -79.36% |
| November, 2026 | $3.3647 | $3.1723 | $3.7305 | -80.66% |
| December, 2026 | $3.1552 | $3.1452 | $3.4389 | -81.87% |
Adma Biologics Inc Stock (ADMA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Adma Biologics Inc (ADMA) is $3.8391, with a high forecast of $4.6246 and a low forecast of $3.0536. This indicates an -77.94% decrease from the last price of $17.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.3336 | $3.0536 | $3.3436 | -80.84% |
| February, 2027 | $3.582 | $3.2657 | $3.7299 | -79.41% |
| March, 2027 | $3.3426 | $3.2326 | $3.5841 | -80.79% |
| April, 2027 | $3.471 | $3.2368 | $3.5589 | -80.05% |
| May, 2027 | $3.6794 | $3.3752 | $3.7044 | -78.85% |
| June, 2027 | $3.7199 | $3.4657 | $3.8265 | -78.62% |
| July, 2027 | $3.9283 | $3.5462 | $3.9983 | -77.42% |
| August, 2027 | $4.0967 | $3.9204 | $4.2617 | -76.46% |
| September, 2027 | $4.1572 | $3.543 | $4.2172 | -76.11% |
| October, 2027 | $4.3256 | $3.9756 | $4.3256 | -75.14% |
| November, 2027 | $4.4441 | $4.0277 | $4.4741 | -74.46% |
| December, 2027 | $4.5146 | $4.1146 | $4.6246 | -74.05% |
Adma Biologics Inc Stock (ADMA) Price Forecast for 2028
In 2028, Adma Biologics Inc (ADMA) is projected to reach an average price of $5.4703, with a high projection of $6.5392 and a low estimate of $4.4014. This indicates an -68.56% fall from the last price of $17.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.963 | $4.4567 | $5.003 | -71.48% |
| February, 2028 | $4.5914 | $4.4014 | $5.0751 | -73.61% |
| March, 2028 | $4.9919 | $4.5735 | $5.0198 | -71.31% |
| April, 2028 | $5.4303 | $4.6461 | $5.6482 | -68.79% |
| May, 2028 | $5.8408 | $5.2066 | $5.9908 | -66.43% |
| June, 2028 | $5.6992 | $5.4592 | $6.175 | -67.25% |
| July, 2028 | $5.7877 | $5.5613 | $6.0977 | -66.74% |
| August, 2028 | $5.3082 | $5.2582 | $5.9148 | -69.49% |
| September, 2028 | $5.5966 | $5.1674 | $5.6945 | -67.84% |
| October, 2028 | $5.695 | $5.2987 | $5.8308 | -67.27% |
| November, 2028 | $6.2955 | $5.6571 | $6.5392 | -63.82% |
| December, 2028 | $5.9439 | $5.8539 | $6.3476 | -65.84% |
Adma Biologics Inc Stock (ADMA) Price Forecast for 2029
The 2029 price forecast for Adma Biologics Inc Stock (ADMA) is $7.2325 on average, with a high prediction of $9.1112 and a low estimate of $5.3539. This represents an -58.43% decrease from the previous price of $17.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.4144 | $5.6831 | $6.4444 | -63.14% |
| February, 2029 | $6.2229 | $6.0829 | $6.9207 | -64.24% |
| March, 2029 | $6.0113 | $5.865 | $6.2992 | -65.45% |
| April, 2029 | $5.4997 | $5.4397 | $6.1234 | -68.39% |
| May, 2029 | $6.0702 | $5.3539 | $6.3202 | -65.11% |
| June, 2029 | $6.1186 | $5.9486 | $6.3744 | -64.84% |
| July, 2029 | $6.837 | $5.9128 | $6.927 | -60.71% |
| August, 2029 | $7.5175 | $6.6891 | $7.7375 | -56.80% |
| September, 2029 | $7.5959 | $7.3559 | $7.7938 | -56.35% |
| October, 2029 | $8.6365 | $7.418 | $8.8165 | -50.37% |
| November, 2029 | $8.6249 | $8.2478 | $9.1086 | -50.43% |
| December, 2029 | $8.415 | $8.21 | $9.1112 | -51.64% |
Adma Biologics Inc Stock (ADMA) Price Forecast for 2030
Adma Biologics Inc Stock (ADMA) is expected to reach an average price of $7.098 in 2030, with a high forecast of $9.0499 and a low forecast of $5.1461. This signifies an -59.21% decrease from the last price of $17.40.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.276 | $6.972 | $8.4442 | -58.18% |
| February, 2030 | $7.5979 | $7.0594 | $7.6179 | -56.33% |
| March, 2030 | $7.0497 | $7.0297 | $7.6821 | -59.48% |
| April, 2030 | $8.0015 | $6.5789 | $8.0815 | -54.01% |
| May, 2030 | $8.0075 | $7.7157 | $9.0499 | -53.98% |
| June, 2030 | $8.3694 | $7.3659 | $8.6194 | -51.90% |
| July, 2030 | $8.0904 | $7.5604 | $8.862 | -53.50% |
| August, 2030 | $7.8522 | $7.4872 | $8.4946 | -54.87% |
| September, 2030 | $8.159 | $7.214 | $8.274 | -53.11% |
| October, 2030 | $7.1801 | $7.1051 | $8.3124 | -58.74% |
| November, 2030 | $5.7469 | $5.4519 | $7.6593 | -66.97% |
| December, 2030 | $6.7087 | $5.1461 | $7.1903 | -61.44% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):